SCHEMBL16654268

SCHEMBL16654268

O=C(c1ccco1)N(Cc1cc(-c2ccco2)on1)C1CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 6/20 0.48
▸ TSHR P16473 2/20 0.46
▸ ALDH1A1 P00352 5/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ EPHX2 P34913 1/20 0.45
▸ SCD O00767 1/20 0.45
▸ SCD5 Q86SK9 1/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ SLC6A9 P48067 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654083 0.86 ALDH1A1 (0.52) OPRM1TSHRALDH1A1KMT2ANPC1
SCHEMBL1474547 0.69 NOTUM (0.59) TSHRALDH1A1KMT2AEPHX2SCD5
SCHEMBL16654037 0.69 SLC6A9 (0.46) OPRM1TSHRALDH1A1KMT2ANPC1
SCHEMBL1475165 0.68 ALDH1A1 (0.62) ALDH1A1KMT2AEPHX2SCDSCD5
SCHEMBL16654340 0.67 ALDH1A1 (0.54) OPRM1TSHRALDH1A1KMT2ANPC1
SCHEMBL31098717 0.67 OPRM1 (0.47) OPRM1TSHRALDH1A1KMT2ANPC1
SCHEMBL10274628 0.66 RAB9A (0.51) TSHRALDH1A1KMT2AEPHX2NPC1
SCHEMBL20507209 0.66 RAB9A (0.52) TSHRALDH1A1KMT2AEPHX2NPC1
SCHEMBL1477034 0.66 EPHX2 (0.47) TSHRALDH1A1KMT2AEPHX2NPC1
SCHEMBL14174990 0.66 OPRM1 (0.46) OPRM1TSHRALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160255836-A1 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-09-08 — — US claimed
EP-3057423-A2 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES Bayer CropScience Aktiengesellschaft (DE) 2016-08-24 — — EP claimed
WO-2015055706-A2 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2015-04-23 — — WO claimed
US-10076116-B2 N-cycloalkyl-N-(biheterocyclymethylene)-(thio)carboxamide derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-09-18 — — US disclosed
US-20160255836-A1 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-09-08 — — US disclosed
EP-3057423-A2 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES Bayer CropScience Aktiengesellschaft (DE) 2016-08-24 — — EP disclosed
WO-2015055706-A2 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2015-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10076116-B2 N-cycloalkyl-N-(biheterocyclymethylene)-(thio)carboxamide derivatives CBR3, CYP51A1, NIT2 OPRM1 4595/4885TSHR 2593/4885ALDH1A1 3279/4885
US-20160255836-A1 N-CYCLOALKYL-N-(BIHETEROCYCLYMETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES CBR3, CYP51A1, NIT2 OPRM1 4595/4885TSHR 2593/4885ALDH1A1 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback